<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005528'>Bone marrow failure</z:hpo> encompasses a broad spectrum of disorders including aplastic, dysmyelopoietic and myelophtisic <z:hpo ids='HP_0001903'>anemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, these <z:hpo ids='HP_0001903'>anemias</z:hpo> were characterized according to the degree of erythroid proliferation and efficiency of erythropoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>Total erythropoietic activity was evaluated in 43 patients by measuring the erythron transferrin uptake (ETU) </plain></SENT>
<SENT sid="3" pm="."><plain>It averaged 20% of basal (range 3-43%) in 13 patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 75% of basal (range 60-103%) in 3 patients with extensive bone marrow infiltration by neoplastic cells, 131% of basal (range 50-217%) in 16 patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo>, and 452% of basal (range 63-720) in 11 patients with idiopathic refractory siderobastic <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Respective efficiencies of erythropoiesis were 74% in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 70% with bone marrow infiltration, 46% in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo>, and 14% in <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Based on the ETU, patients could be categorized into absolute marrow failure, relative marrow failure, and adequate erythropoietic response to <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>This simple determination of proliferating activity of the erythroid marrow can provide useful information on the pathophysiology of marrow failure and a basis for the selection of therapeutic approaches </plain></SENT>
</text></document>